Essilor International SA (EI) Given a €127.00 Price Target by Credit Suisse Group AG Analysts
Essilor International SA (EPA:EI) has been given a €127.00 ($136.56) price target by equities research analysts at Credit Suisse Group AG in a report issued on Friday. The firm presently has a “buy” rating on the stock.
A number of other research firms have also recently weighed in on EI. Barclays PLC set a €130.00 ($139.78) price target on shares of Essilor International SA and gave the company a “buy” rating in a report on Thursday, March 9th. HSBC Holdings plc set a €132.00 ($141.94) price target on shares of Essilor International SA and gave the company a “buy” rating in a report on Friday, January 27th. JPMorgan Chase & Co. set a €94.00 ($101.08) price target on shares of Essilor International SA and gave the company a “neutral” rating in a report on Thursday, January 5th. Goldman Sachs Group Inc restated a “neutral” rating on shares of Essilor International SA in a report on Wednesday, January 18th. Finally, Morgan Stanley restated a “buy” rating on shares of Essilor International SA in a report on Wednesday, February 1st. One research analyst has rated the stock with a sell rating, three have given a hold rating and nine have given a buy rating to the company’s stock. Essilor International SA currently has a consensus rating of “Buy” and a consensus price target of €120.46 ($129.53).
Shares of Essilor International SA (EPA:EI) opened at 112.55 on Friday. Essilor International SA has a one year low of €93.41 and a one year high of €124.55. The stock has a market capitalization of €24.24 billion and a PE ratio of 30.34. The firm’s 50-day moving average is €109.11 and its 200-day moving average is €107.75.
Your IP Address:
Essilor International SA Company Profile
Essilor International SA, formerly Essilor International Compagnie Generale D’Optique SA, is an ophthalmic optics company. The Company designs, manufactures and markets a range of lenses to improve and protect eyesight. It also develops and markets equipment for prescription laboratories, and instruments and services for eye care professionals.
Receive News & Ratings for Essilor International SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Essilor International SA and related companies with MarketBeat.com's FREE daily email newsletter.